Raffaele Landolfi

Plain English
This study looked at how to measure the effectiveness of seasonal influenza vaccines by identifying and ranking different health outcomes that show how well the vaccines work. Researchers found 489 possible outcomes, narrowed it down to 20 important ones, and confirmed that the most serious outcomes—like hospital visits and deaths from the flu—are the most crucial for assessing vaccine efficacy, with high importance ratings (at least 8 out of 9). This matters because focusing on these severe outcomes can lead to better decisions about vaccination strategies. Who this helps: This helps patients and healthcare providers by improving vaccination practices and public health policies.

Plain English
This study examined a system created to improve how hospitals manage COVID-19 patients by using a specialized data system that collects and analyzes patient information in real time. Researchers looked at 5,528 patients and found that those who died from the virus were generally older, had more underlying health issues, and showed certain symptoms like difficulty breathing. This system helps healthcare providers make better decisions quickly, which is crucial for managing patients effectively during emergencies like pandemics. Who this helps: This helps doctors and healthcare providers in managing COVID-19 patients more effectively.

Plain English
The R.Evolution project studied the biggest challenges facing clinical research in Italy and proposed ways to improve it. Researchers found four main problem areas: the difficulty of getting studies approved, managing research operations, understanding patient needs, and ensuring that staff are well-trained. They identified that many people aren't aware of the benefits of clinical research, and there is a lack of trained professionals, which complicates the process. The project suggests strategies like better training for staff and simplifying administrative tasks to make clinical research more effective. Who this helps: This benefits patients, doctors, and healthcare organizations involved in clinical research.

Plain English
This study looked at how platelets, which are blood cells involved in clotting, contribute to inflammation in patients with nonalcoholic fatty liver disease (NAFLD). Researchers found that NAFLD patients had higher levels of inflammatory markers compared to healthy individuals, with significant changes noted in 24 NAFLD patients versus 17 healthy volunteers. Specifically, platelet changes were linked to the severity of liver disease, as higher platelet accumulation and inflammation in the liver corresponded with worse NAFLD activity scores. Who this helps: This helps patients with nonalcoholic fatty liver disease by providing insights into the disease's progression and potential treatment targets.

Plain English
This study looked at the heart damage in 189 patients diagnosed with COVID-19 and found that 16% had myocardial injury. These patients were older, had more heart-related health issues, and experienced higher rates of severe outcomes, including a significantly higher risk of death (54.8% vs. 9.5% for those without heart injury). The researchers concluded that measuring troponin levels could help doctors identify patients at higher risk of serious complications from COVID-19 early on. Who this helps: This information is beneficial for doctors treating COVID-19 patients, particularly those with existing heart conditions.

Plain English
This study examined the health benefits of the Montreal Protocol, which aims to protect the ozone layer by reducing harmful chemicals. Researchers found that from 1890 to 2100, this protocol is expected to prevent about 443 million cases of skin cancer and 63 million cases of cataracts in the U.S., along with avoiding 2.3 million deaths from skin cancer. The strengthened version of the Protocol has led to even greater reductions, including 230 million fewer skin cancer cases and 33 million fewer cataract cases compared to the original version. Who this helps: This helps patients by reducing their risk of skin cancer and cataracts.

Plain English
This study focuses on a case of an 18-year-old man who had severe symptoms like muscle pain, skin bruising, and bleeding gums due to scurvy, which is a vitamin C deficiency. Tests showed he had very low levels of vitamin C in his blood. The case highlights that scurvy can occur in people who restrict their diets, especially if they also have related health issues like anxiety or celiac disease. Who this helps: This helps patients with restrictive diets or related health conditions.

Plain English
This study looked at how low-dose aspirin can help people with high blood pressure and heart issues by preventing certain harmful processes in the body. Researchers found that in 22 patients with high blood pressure, there was more of a substance called thromboxane, which is linked to increased blood pressure and heart damage. They showed that giving low-dose aspirin reduced blood pressure and heart damage in mice by blocking thromboxane production. Who this helps: This benefits patients with high blood pressure and heart conditions.

Plain English
This study looked at how certain molecules in the body are linked to blood vessel problems in people with diabetes, focusing on those influenced by fat and immune system cells. Researchers found that specific proteins, like resistin and sortilin, play a key role in communication between fat cells and inflammatory cells, while other proteins such as adiponectin and visfatin show potential as important markers for blood vessel disease. Understanding these markers can help doctors make better treatment decisions for patients with diabetes-related vascular issues. Who this helps: This benefits patients with diabetes, particularly those at risk for vascular complications.

Plain English
This study looked at patients with heart failure who still have normal pumping function (HFpEF) to see how common hormonal deficiencies are and how these deficiencies affect heart health. Out of 40 patients, 97.5% had a deficiency in a hormone called DHEA-S, and overall, 80% had deficiencies in two or more hormones. The findings showed that these hormonal issues are linked to problems with heart function, especially in the right side of the heart. Who this helps: This research benefits patients with heart failure and their doctors by highlighting the importance of managing hormone levels for better heart health.

Plain English
This study looked at how many people get sunburned at U.S. beaches and how different behaviors affect this risk. They found that 13.1% of beachgoers reported getting sunburned, with the highest rates among teenagers (16.5%), white individuals (16.0%), and those on the Eastern Seaboard (16.1%). Notably, using multiple types of sun protection cut the chance of getting sunburned by 55% for those spending five or more hours in the sun. This research highlights the importance of promoting better sun safety practices to reduce the risk of sunburn and, ultimately, skin cancer. Who this helps: This helps beachgoers, particularly teenagers and those living near the coast.

Plain English
This study looked at patients with heart failure that maintains their ability to pump blood, known as heart failure with preserved ejection fraction (HFpEF). Researchers found that many patients had deficiencies in important hormones: 87% were low in DHEA-S, 67% in IGF-1, and 42% in testosterone. These deficiencies were linked to lower levels of antioxidants in the body and worse heart function, indicating that hormonal imbalances may worsen heart health. Who this helps: This research benefits patients with heart failure, especially those experiencing hormonal deficiencies.

Plain English
This study looked at whether giving older COVID-19 patients convalescent plasma, which is blood from people who have recovered from the disease, can help prevent their pneumonia from getting worse. The researchers are testing this on patients aged 65 and older with pneumonia and other health issues. They will assess how many patients avoid worsening symptoms by day 14, along with other factors like viral load and antibody levels. Who this helps: This helps older COVID-19 patients with pre-existing health conditions.

Plain English
This study looked at how the coronavirus (SARS-CoV-2) affects heart health, focusing on whether the damage is caused directly by the virus or by the body's immune response to the virus. Researchers found that the virus is linked to heart problems, but they emphasize that more research is needed to fully understand how this happens. Understanding the connection between COVID-19 and heart health is important because it can help guide better treatment approaches for affected patients. Who this helps: This helps patients with COVID-19 and heart issues, as well as doctors managing their care.

Plain English
This study looked at patients with diabetes who have peripheral artery disease (PAD) and how levels of a protein called sortilin affect their risk for serious heart and limb problems after a specific treatment called revascularization. Researchers found that patients with higher sortilin levels (2.46 ng/mL for those who had major heart events and 2.10 ng/mL for those with serious limb issues) were more likely to experience these adverse events compared to those with lower levels. These findings are important because measuring sortilin levels could help doctors identify patients at higher risk for complications after treatment, allowing for better care management. Who this helps: This research benefits patients with diabetes and peripheral artery disease by helping doctors predict and manage their risk of serious health events.

Plain English
This study looked at the levels of a protein called omentin-1 in 207 diabetic patients who had poor blood flow in their legs and were undergoing a specific treatment to restore blood flow. The findings showed that patients with lower levels of omentin-1 (around 26 ng/mL) had higher rates of serious heart and limb problems within a year after treatment compared to those with higher levels (around 31 ng/mL). This is important because it suggests that measuring omentin-1 could help doctors identify patients at greater risk for complications after treatment, potentially guiding better care. Who this helps: This helps patients with diabetes and doctors managing their vascular health.

Plain English
This study looked at how effective Sarilumab, a medication that blocks a specific signal involved in inflammation, is for treating severe pneumonia caused by the SARS-CoV-2 virus. Out of 53 patients, 89.7% experienced significant improvement after treatment, with 70.6% being discharged from the hospital and a low mortality rate of 5.7%. These findings suggest that Sarilumab can be an important treatment option for patients with severe COVID-19 pneumonia, helping them recover more quickly and potentially reducing the need for intensive care. Who this helps: This helps patients suffering from severe COVID-19 pneumonia.

Plain English
This research examined how stem cell therapy might help treat peripheral artery disease, a condition often worsened by diabetes that can lead to serious health problems, including amputations. The review highlighted that current treatments have not effectively solved this issue, and stem cells could be a promising new approach. This is important because improving treatment options could significantly enhance patients' quality of life and reduce serious complications. Who this helps: Patients with peripheral artery disease and diabetes.

Plain English
This study looked at how gut bacteria (microbiota) affect diabetic patients with blood vessel problems, specifically conditions like peripheral artery disease. Researchers found that these bacteria could influence the progression of atherosclerosis (hardening of the arteries) in diabetic patients, which is crucial since diabetes often leads to serious complications. Understanding this link could help personalize treatments and address why some patients experience more severe issues than others. Who this helps: This benefits patients with diabetes and their doctors by providing new insights for better treatment approaches.

Plain English
This research paper looks at the role of a protein called High Mobility Group Box-1 (HMGB1) in complications caused by diabetes mellitus (DM). The study found that HMGB1 is linked to various diabetes-related issues affecting the heart, kidneys, and nervous system. Understanding HMGB1's role can help identify new ways to prevent or treat these complications, ultimately improving patient care. Who this helps: This helps patients with diabetes and their doctors.

Plain English
This study looked at sortilin, a protein found in the blood, to see how it relates to peripheral artery disease (PAD) in people with type 2 diabetes who are not taking statins. The researchers found that patients with significant PAD had much higher levels of sortilin (1.61 ng/mL) compared to those without PAD (0.67 ng/mL), suggesting that higher sortilin levels could be linked to worse artery health. Understanding sortilin levels may help identify patients at risk for serious circulation problems in the future. Who this helps: This helps patients with diabetes and doctors managing their care.

Plain English
This study looked at the levels of a protein called omentin-1 in people with type 2 diabetes to see how it relates to peripheral artery disease (PAD). Researchers found that patients with PAD had much lower omentin-1 levels (29.46 ng/mL) compared to those without PAD (49.24 ng/mL), and lower levels were linked to more severe disease. This is important because it may help identify patients at greater risk for PAD and lead to better management of their condition. Who this helps: Patients with type 2 diabetes and peripheral artery disease.

Plain English
This study looked at how certain proteins in the body, called cytokines, affect the success of a specific surgery (endovascular revascularization) for patients with diabetes and severe leg circulation issues. Researchers found that patients with high levels of cytokines like osteoprotegerin, tumor necrosis factor-alpha, interleukin-6, and C-reactive protein were more likely to experience serious problems like limb events or heart issues after the procedure. Specifically, higher levels correlated with worse outcomes over the following year, suggesting that measuring these cytokines can help predict which patients might struggle after surgery. Who this helps: This information benefits patients with diabetes and peripheral artery disease by identifying those at higher risk for complications after surgery.

Plain English
This study focused on how the MEDS score and vitamin D levels are linked to survival rates in patients with sepsis, a life-threatening condition. Researchers found that out of 88 septic patients aged around 75, about 26% died within 28 days and 38% within 90 days. Higher MEDS scores were associated with increased mortality, and low vitamin D levels predicted a worse outcome, making values below 7 ng/ml particularly concerning. Who this helps: This research benefits doctors and healthcare providers by identifying which patients are at higher risk of dying from sepsis, allowing for better care strategies.

Plain English
This study looked at how levels of a substance called fecal calprotectin relate to the treatment outcomes of patients with Clostridium difficile infection (CDI). Researchers found that patients with higher fecal calprotectin levels (285.5 µg/g) tended to have longer-lasting diarrhea compared to those with lower levels (150.7 µg/g). Understanding these levels can help doctors make better decisions about treatment duration and options, potentially improving patient care. Who this helps: This helps doctors and patients with Clostridium difficile infections.

Plain English
This study looked at the heart-related side effects of two cancer treatments, anthracycline and trastuzumab, in women with breast cancer. Researchers found that early detection of heart problems can improve treatment outcomes, allowing doctors to continue chemotherapy without stopping due to heart issues. This is important because as more women survive breast cancer, managing heart health becomes crucial for their overall well-being. Who this helps: This helps patients undergoing breast cancer treatment and their healthcare providers.

Plain English
This study looked at scurvy, a disease caused by a lack of vitamin C, which affects the body's connective tissues. Researchers found a young woman with purpura (purple spots on the skin) due to scurvy, which was diagnosed after ruling out other causes. After receiving daily vitamin C infusions, her condition improved, showing the importance of prompt treatment in cases of malnutrition-related scurvy. Who this helps: This helps patients, particularly those with a history of malnutrition.

Plain English
This study looked at two methods for diagnosing peripheral arterial disease (PAD) — ultrasonography and the ankle-brachial index (ABI) — to see which one is better at identifying the disease and its connection to other heart-related risk factors. Researchers found that ultrasonography was more effective, showing stronger links to risks like age, male gender, smoking, high blood pressure, diabetes, and previous heart problems. This is important because it means using ultrasonography can help detect PAD earlier and better, improving cardiovascular risk assessments. Who this helps: This helps doctors and patients, especially those at risk for heart disease.

Plain English
This study examined the presence of specific antibodies in people with a serious foot condition called Charcot neuroarthropathy (CN), which often affects those with type 2 diabetes. Researchers found that out of 124 participants, those with CN showed a significant increase in antibodies related to modified type II collagen, suggesting an autoimmune response, while those with diabetic neuropathy also exhibited similar antibody responses. This discovery is important because it may help explain how the body’s immune system contributes to the progression of CN. Who this helps: This benefits patients with Charcot neuroarthropathy and their doctors by providing insights into the autoimmune factors at play in this condition.

Plain English
This study looked at a rare lung condition called intralobar pulmonary sequestration in a 56-year-old woman, which caused her levels of a cancer marker, CA 19-9, to rise. The raised CA 19-9 led to unnecessary and extensive tests for cancer, but knowing about this lung condition can help doctors avoid misdiagnosis and reduce unnecessary procedures. Being aware of this connection can lower the number of invasive tests and antibiotics prescribed. Who this helps: This helps doctors by improving diagnosis and reducing unnecessary testing for patients.

Plain English
This study looked at how sepsis, a severe condition caused by infections, is being managed in Internal Medicine wards, especially since more patients are being treated there instead of Intensive Care Units. Researchers found that adherence to treatment guidelines is improving patient outcomes, with more consistent use of tools like the SOFA score for identifying sepsis, and methods like ultrasound and lab tests to guide treatment. This matters because better management of sepsis can significantly reduce complications and deaths, which is crucial as the number of patients with this condition continues to rise. Who this helps: This helps patients with sepsis and the doctors caring for them.

Plain English
This study looked at blood levels of certain proteins in nearly 1,400 people with type 2 diabetes, comparing those with peripheral artery disease (PAD) to those without. It found that patients with PAD had significantly higher levels of two proteins, HMGB-1 and OPG, along with other inflammatory markers, which were linked to more severe PAD symptoms. This is important because it highlights potential markers that could help doctors identify and manage PAD in diabetes patients more effectively, possibly leading to better treatment outcomes. Who this helps: Patients with type 2 diabetes and peripheral artery disease.

Plain English
This research paper looks at how celiac disease (CD), which is an autoimmune condition, relates to atherosclerosis (AS) and cardiovascular diseases (CV). It found that people with CD have a higher risk of developing AS, evidenced by thicker carotid arteries and other signs of heart problems. Specifically, patients with CD are more likely to have serious heart conditions like heart attacks and heart failure compared to those without the disease. This is important because it highlights the need for better heart health monitoring in people with CD to prevent these complications. Who this helps: This helps patients with celiac disease and their healthcare providers.

Plain English
This study looked at a young woman with a long-lasting fever and an enlarged spleen due to a difficult-to-diagnose heart infection called endocarditis, which did not show up in standard blood tests. Although her blood cultures were negative, advanced tests revealed she had an infection caused by Bartonella henselae, leading to successful heart valve surgery and antibiotic treatment. This is important because it highlights that some heart infections may not show up in regular tests, and specialized methods are needed for accurate diagnosis and treatment. Who this helps: This helps patients with unexplained fevers and doctors diagnosing complex infections.

Plain English
This study looked at how a protein called HMGB1 affects the ability of human fat-derived stem cells to help restore blood flow in mice with a condition called peripheral arterial disease (PAD). Researchers found that when they combined these stem cells with HMGB1, blood flow improved significantly, leading to better vessel growth. However, blocking HMGB1 or another growth factor reduced this beneficial effect. This research highlights a potential new way to use stem cells in treating PAD, which could help more effectively restore blood flow to those affected. Who this helps: This benefits patients with peripheral arterial disease.

Plain English
This study looked at human cells called megakaryocytes, which produce platelets, in patients with a rare bleeding disorder known as Gray Platelet Syndrome (GPS). Researchers found that while the cells developed normally, they had fewer important proteins and struggled to create platelets, leading to low platelet counts. Understanding these specific problems helps to identify the reasons behind the bleeding issues in GPS patients and could lead to better treatments. Who this helps: This helps patients with Gray Platelet Syndrome and their doctors.

Plain English
This study looks at isolated distal deep vein thrombosis (IDDVT), a type of blood clot that usually resolves on its own but can still pose risks if not managed properly. Researchers found that while most IDDVT cases are harmless, there isn’t a clear agreement among doctors about the best way to treat it, leading to varied treatment approaches. This matters because inconsistent treatment can affect patient safety and outcomes, and experts are calling for a consensus to ensure better care for these patients. Who this helps: This helps patients with isolated distal deep vein thrombosis and their healthcare providers.

Plain English
This study looked at how doctors in internal medicine and emergency medicine view the risk of blood clots, known as venous thromboembolism (VTE), in hospitalized patients. Among 742 patients analyzed, only 30% of those in emergency departments received preventative treatment with a medication called low-molecular-weight heparin, which was used more often in internal medicine departments. This difference matters because patients in emergency care may not be getting the same level of prevention for blood clots, indicating a need for new risk assessment tools tailored to emergency medicine. Who this helps: This helps patients in emergency departments by highlighting the need for better prevention of blood clots.

Plain English
This research looked at how changing the bacteria in our intestines might help treat conditions that cause inflammation, like ulcerative colitis and Crohn's disease. The review found that probiotics showed some promise, helping reduce symptoms in ulcerative colitis and pouchitis but not in Crohn's disease. Moreover, fecal microbiota transplantation (FMT) was found to be an effective treatment for recurring Clostridium difficile infections. Understanding how to modify gut bacteria could lead to new treatments for these diseases. Who this helps: Patients suffering from inflammatory bowel diseases and gut infections.

Plain English
This study looked at a specific part of the immune system related to antibodies in 167 people with Crohn's disease compared to 64 healthy individuals. The researchers found that levels of certain antibodies, specifically IgA and IgG ASCA, were significantly different between the two groups, with p-values indicating strong statistical significance (p<0.001). Importantly, they concluded that a specific immune enhancer isn't involved in causing Crohn's and noted that patients with Crohn's had lower levels of IgG4, which could be connected to inflammation in the body. Who this helps: This research benefits patients with Crohn's disease by improving understanding of the disease's immune factors.

Plain English
This study examined venous thromboembolism (VTE), a serious blood clot condition, in critically ill patients across three different age groups: under 60, 60 to 75, and over 75 years old. Researchers analyzed data from 187 patients with VTE and 350 control patients and discovered that different risk factors were significant for each age group, such as hormone treatments and family history in younger patients, and immobilization and chronic venous issues in older patients. The study also developed specific risk scores for each age group that improved the ability to predict thromboembolic risk compared to existing methods. Who this helps: This benefits patients at risk for blood clots, especially older adults and those with specific health challenges.

Plain English
This study looked at a substance called FGF23 in Italian patients with type 2 diabetes to see how it relates to vascular problems in their legs, known as peripheral arterial disease (PAD). Researchers found that patients with PAD had higher levels of FGF23 (about 69.3 pg/mL) compared to those without PAD (about 42.98 pg/mL), and higher levels of FGF23 were linked to a serious condition called critical limb ischemia. This matters because it suggests that measuring FGF23 could help identify diabetes patients at risk for severe leg issues. Who this helps: This benefits patients with type 2 diabetes and their doctors by providing a potential way to assess risk for severe leg complications.

Plain English
This study looked at how certain genetic changes in the RANKL gene might be linked to a history of ischemic stroke in Italian people. Researchers studied 487 stroke patients and 543 people without strokes, finding that a specific genetic variant called rs9533156 was present in 55% of stroke patients compared to only 36.5% of those without, showing a strong connection to stroke risk. This discovery highlights the importance of genetic factors in predicting stroke, which could lead to better prevention strategies in the future. Who this helps: Patients at risk of ischemic stroke and their healthcare providers.

Plain English
This study examined why doctors sometimes give blood clot prevention medication (thromboprophylaxis) to patients who are not at high risk for clots. Researchers found that 16.5% of patients without major risk factors were still given this treatment. The main reasons identified for this overuse included the presence of severe infections and chronic vein issues, along with the patients' age. Who this helps: This information can help doctors make better decisions about when to prescribe blood clot prevention medication, ensuring it's used appropriately.